SENATE BILL No. 1237 No

SENATE BILL No. 1237 No. SENATE BILL

SENATE BILL No. 1237

March 26, 2008, Introduced by Senators SWITALSKI, GLEASON, ANDERSON, KAHN, PAPPAGEORGE, BIRKHOLZ and JACOBS and referred to the Committee on Health Policy.

A bill to amend 1978 PA 368, entitled

"Public health code,"

by amending section 7216 (MCL 333.7216), as amended by 1999 PA

42.

THE PEOPLE OF THE STATE OF MICHIGAN ENACT:

1 Sec. 7216. (1) The following controlled substances are

2 included in schedule 3:

3 (a) Unless listed in another schedule, any material,

4 compound, mixture, or preparation containing any quantity of the

5 following substances having a potential for abuse associated with

6 a stimulant effect on the central nervous system, including their

7 salts, isomers, including optical, position, or geometric

8 isomers, and salts of the isomers if the existence of the salts,

9 isomers, and salts of isomers is possible within the specific

SENATE BILL No. 1237

06180'07 KKR

1 chemical designation:

2 Benzphetamine Mediatric tabs 3 Chlorphentermine Mediatric liquid 4 Clortermine Phendimetrazine 5 Edrisal tabs Special formula 711 tabs 6 Genegesic caps Thora Dex No. 1 tab 7 Hovizyme tabs Thora Dex No. 2 tab 8 Mazindol

9 (b) Unless listed in another schedule, any material,

10 compound, mixture, or preparation containing any quantity of the

11 following substances having a potential for abuse associated with

12 a depressant effect on the central nervous system, including

13 their salts, isomers, including optical, position, or geometric

14 isomers, and salts of the isomers if the existence of the salts,

15 isomers, and salts of isomers is possible within the specific

16 chemical designation:

17 Chlorhexadol Phencyclidine 18 Glutethimide Sulfondiethylmethane 19 Lysergic acid Sulfonethylmethane 20 Lysergix acid amide Sulfonmethane 21 Methyprylon

22 (c) Nalorphine.

23 (d) Any substance that contains any quantity of a derivative

24 of barbituric acid, or any salt of a derivative of barbituric

25 acid, except those substances that are specifically listed in

26 other schedules.

06180'07 KKR

1 (e) A compound, mixture, or preparation containing

2 amobarbital, secobarbital, pentobarbital, or a salt of

3 amobarbital, secobarbital, or pentobarbital, and 1 or more other

4 active medicinal ingredients that are not listed in a schedule.

5 (f) A suppository dosage form containing amobarbital,

6 secobarbital, pentobarbital, or a salt of amobarbital,

7 secobarbital, or pentobarbital and approved by the food and drug

8 administration for marketing only as a suppository.

9 (g) Any material, compound, mixture, or preparation

10 containing limited quantities of any of the following narcotic

11 drugs or their salts:

12 (i) Not more than 1.8 grams of codeine, or any of its salts,

13 per 100 milliliters or not more than 90 milligrams per dosage

14 unit, with an equal or greater quantity of an isoquinoline

15 alkaloid of opium.

16 (ii) Not more than 1.8 grams of codeine, or any of its salts,

17 per 100 milliliters or not more than 90 milligrams per dosage

18 unit, with 1 or more active nonnarcotic ingredients in recognized

19 therapeutic amounts.

20 (iii) Not more than 300 milligrams of dihydrocodeinone, or any

21 of its salts, per 100 milliliters or not more than 15 milligrams

22 per dosage unit, with a fourfold or greater quantity of an

23 isoquinoline alkaloid of opium.

24 (iv) Not more than 300 milligrams of dihydrocodeinone, or any

25 of its salts, per 100 milliliters or not more than 15 milligrams

26 per dosage unit, with 1 or more active nonnarcotic ingredients in

27 recognized therapeutic amounts.

06180'07 KKR

1 (v) Not more than 1.8 grams of dihydrocodeine, or any of its

2 salts, per 100 milliliters or not more than 90 milligrams per

3 dosage unit, with 1 or more active nonnarcotic ingredients in

4 recognized therapeutic amounts.

5 (vi) Not more than 300 milligrams of ethylmorphine, or any of

6 its salts, per 100 milliliters or not more than 15 milligrams per

7 dosage unit, with 1 or more ingredients in recognized therapeutic

8 amounts.

9 (vii) Not more than 500 milligrams of opium per 100

10 milliliters or per 100 grams, or not more than 25 milligrams per

11 dosage unit, with 1 or more active nonnarcotic ingredients in

12 recognized therapeutic amounts.

13 (viii) Not more than 50 milligrams of morphine, or any of its

14 salts, per 100 milliliters or per 100 grams, with 1 or more

15 active nonnarcotic ingredients in recognized therapeutic amounts.

16 (h) Any material, compound, mixture, or preparation

17 containing any quantity of ketamine, a salt of ketamine, an

18 isomer of ketamine, or a salt of an isomer of ketamine.

19 (I) EXCEPT AS OTHERWISE PROVIDED IN THIS SECTION, ANABOLIC

20 STEROIDS.

21 (2) The administrator may promulgate rules to except a

22 compound, mixture, or preparation containing any stimulant or

23 depressant substance listed in subsection (1)(a) and (b) from the

24 application of all or any part of this article if the compound,

25 mixture, or preparation contains 1 or more active medicinal

26 ingredients not having a stimulant or depressant effect on the

27 central nervous system and if the admixtures are in combinations,

06180'07 KKR

1 quantity, proportion, or concentration that vitiate the potential

2 for abuse of the substances having a stimulant or depressant

3 effect on the central nervous system.

4 (3) AS USED IN THIS SECTION, "ANABOLIC STEROID" MEANS ANY

5 DRUG OR HORMONAL SUBSTANCE THAT IS CHEMICALLY AND

6 PHARMACOLOGICALLY RELATED TO TESTOSTERONE, OTHER THAN ESTROGENS,

7 PROGESTINS, AND CORTICOSTEROIDS, AND THAT PROMOTES MUSCLE GROWTH,

8 INCLUDING ANY SALT, ESTER, OR ISOMER OF A DRUG OR SUBSTANCE

9 LISTED IN THIS SUBSECTION, IF THAT SALT, ESTER, OR ISOMER

10 PROMOTES MUSCLE GROWTH. ANABOLIC STEROID INCLUDES ANY OF THE

11 FOLLOWING:

12 (A) BOLDENONE.

13 (B) CHLOROTESTOSTERONE (4-CHLOROTESTOSTERONE).

14 (C) CHORIONIC GONADOTROPIN.

15 (D) CLOSTEBOL.

16 (E) DEHYDROCHLORMETHYLTESTOSTERONE.

17 (F) DIHYDROTESTOSTERONE (4-DIHYDROTESTOSTERONE).

18 (G) DROSTANOLONE.

19 (H) ETHYLESTRENOL.

20 (I) FLUOXYMESTERONE.

21 (J) FORMEBOLONE.

22 (K) HUMAN GROWTH HORMONE.

23 (l) MESTEROLONE.

24 (M) METHANDIENONE.

25 (N) METHANDRANONE.

26 (O) METHANDRIOL.

27 (P) METHANDROSTENOLONE.

06180'07 KKR

1 (Q) METHENOLONE.

2 (R) METHYLTESTOSTERONE.

3 (S) MIBOLERONE.

4 (T) NANDROLONE.

5 (U) NORETHANDROLONE.

6 (V) OXANDROLONE.

7 (W) OXYMESTERONE.

8 (X) OXYMETHOLONE.

9 (Y) STANOLONE.

10 (Z) STANOZOLOL.

11 (AA) TESTOLACTONE.

12 (BB) TESTOSTERONE.

13 (CC) TESTOSTERONE CYPIONATE.

14 (DD) TESTOSTERONE ENANTHATE.

15 (EE) TESTOSTERONE PROPIONATE.

16 (FF) TRENBOLONE.

17 (4) THE FOLLOWING ANABOLIC STEROID PRODUCTS ARE EXCEPTED

18 FROM ALL SCHEDULES OF CONTROLLED SUBSTANCES:

19 (A) ANABOLIC STEROIDS THAT ARE EXPRESSLY INTENDED FOR

20 ADMINISTRATION THROUGH IMPLANTS TO CATTLE OR OTHER NONHUMAN

21 SPECIES AND THAT ARE APPROVED BY THE FEDERAL FOOD AND DRUG

22 ADMINISTRATION FOR SUCH USE.

23 (B) ESTERIFIED ESTROGENS 1.25 MILLIGRAMS AND METHYL

24 TESTOSTERONE 2.5 MILLIGRAM TABLETS.

25 (C) ESTERIFIED ESTROGENS 0.625 MILLIGRAMS AND METHYL

26 TESTOSTERONE 1.25 MILLIGRAM TABLETS.

27 (D) CONJUGATED ESTROGENS 1.25 MILLIGRAMS AND METHYL

06180'07 KKR

1 TESTOSTERONE 10 MILLIGRAM TABLETS.

2 (E) CONJUGATED ESTROGENS 0.625 MILLIGRAMS AND METHYL

3 TESTOSTERONE 5 MILLIGRAM TABLETS.

4 (F) TESTOSTERONE ENANTHATE 90 MILLIGRAM/MILLILITER AND

5 ESTRADIOL VALERATE 4 MILLIGRAM/MILLILITER INJECTION.

6 (G) TESTOSTERONE CYPIONATE 50 MILLIGRAM/MILLILITER AND

7 ESTRADIOL CYPIONATE 2 MILLIGRAM/MILLILITER INJECTION.

06180'07 Final Page KKR